Prevention of Infections in Cardiac Surgery (PICS): a Cluster-randomized Factorial Cross-over Trial
Starting soon · Phase 4
Conditions studied: Infection, Surgical Site
In brief
The goal of this pragmatic, multi-centre factorial cluster randomized cross-over trial is to assess the efficacy of a combination of cefazolin plus vancomycin compared to cefazolin monotherapy, as well as a comparison of short versus long-term prophylaxis with four study arms: 1) cefazolin short-term, 2) cefazolin long-term, 3) cefazolin plus vancomycin short-term and 4) cefazolin plus vancomycin long-term.
Key facts
- Study ID
- NCT06567808
- Run by
- Hamilton Health Sciences Corporation
- People needed
- 38000
- Starts
- 2026-03-01
- Expected to finish
- 2028-07-30
- Last updated by the study team
- 2026-03-12
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adult patients (≥18 years of age) undergoing open-heart surgery (i.e. sternotomy, including minimally-invasive surgical techniques through mini-sternotomies)
You may not qualify if…
- On systemic antibiotics or with an active bacterial infection at the time of surgery
- Previously enrolled in this trial
- Known to be colonized with methicillin-resistant staphylococcus aureus (MRSA). Where it is unethical to not administer glycopeptides.
- Beta-lactam or vancomycin allergy precluding the use of cefazolin or vancomycin, respectively
- Participation in other studies that may interfere with this trial.
- Patients undergoing cardiac transplant
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.